Miami Cancer Institute
Baptist Health South Florida, the region’s largest not-for-profit healthcare organization with more than 15,500 employees working across seven hospital campuses and more than 50 outpatient facilities throughout Miami-Dade, Monroe, Broward, and Palm Beach counties, is proud and excited to announce the opening of South Florida’s newest resource in the fight against cancer.
Miami Cancer Institute: The future of cancer care has a new world-class home here.
Memorial Sloan Kettering Cancer Center and Miami Cancer Institute have begun a dynamic and forward-thinking collaboration aimed at improving patient access to the latest and most effective cancer treatment advances and the highest caliber of cancer care.
The Miami Cancer Institute at Baptist Health will provide our patients with seamless care from all of our healthcare professionals under one roof. Our brand new, state-of-the-art Institute is fully functional and brings with it a world of opportunities. Imagine adding your talents to the world-class staff of the Miami Cancer Institute — a cornerstone of the future of cancer care, featuring:
• A 305,000 sq. ft. clinical facility combined with a 90,000 sq. ft. research center
• The first facility in South Florida (and one of few nationally) to offer innovative proton therapy
• Comprehensive cancer care (from research and prevention to detection and treatment)
• Special programs for patient, family and community support
We will be the first in South Florida — and among only a handful in the nation — to offer proton therapy. Our comprehensive clinical service offerings will also include:
- diagnostic imaging
- infusion chemotherapy
- bone marrow transplant
- radiation therapies including standard radiation, TomoTherapy, Gamma Knife and CyberKnife® stereotactic radio surgery, in addition to proton therapy.
Miami Cancer Institute will be supported by a clinical and research alliance with one of the leading academic centers in the world. Utilizing cutting-edge translational research and genomic medicine, patients will have access to clinical trials that may lead to monumental treatment breakthroughs.